The addition of chemotherapy to adjuvant radiation is associated with inferior survival outcomes in intermediate-risk HPV-negative HNSCC.
Tasoulas J, Lenze NR, Farquhar D, P Schrank T, Shen C, Shazib MA, Singer B, Patel S, Grilley Olson JE, Hayes DN, Gulley ML, Chera BS, Hackman T, Olshan AF, Weiss J, Sheth S.
Tasoulas J, et al. Among authors: singer b.
Cancer Med. 2021 May;10(10):3231-3239. doi: 10.1002/cam4.3883. Epub 2021 May 2.
Cancer Med. 2021.
PMID: 33934525
Free PMC article.